CooperCompanies to Present at J.P. Morgan Healthcare Conference
CooperCompanies (NYSE: COO) will present virtually at the J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CooperCompanies (NYSE: COO) will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021, at 12:40 PM PT (3:40 PM ET). Al White, President and CEO, will represent the company during the event. Investors can access the live webcast via the Investor Relations section of CooperCompanies' website, with a replay available 24 hours post-presentation. CooperCompanies operates through two units: CooperVision, focusing on vision care, and CooperSurgical, which advances health for women and families. The company is headquartered in San Ramon, California.
Details
News Market Reaction – COO
The recorded move for COO in the trading session of this news was +1.18%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., Dec. 21, 2020 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will present virtually at the J.P. Morgan Healthcare Conference on January 12, 2021. Al White, President and CEO, will represent the Company in a presentation scheduled to begin at 12:40PM PT (3:40PM ET).
This webcast will be available to investors and other interested parties by accessing the Investor Relations section of the CooperCompanies website at http://investor.coopercos.com. A webcast replay will be available approximately 24-hours after the live webcast.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.